Oral medications in Multiple sclerosis therapy – new hope for patients?
Multiple sclerosis is the most common neurological disease, affecting chiefly young people. It leads to damage of the central nervous system due to abnormal activity of autoreactive T cells, which results in damage of myelin sheath of neurons and formation of so-called demyelinating plaques. As a consequence, we can observe a broad spectrum of symptoms, including optic neuritis, pyramidal weakness, sensory disturbances, cerebellar ataxia, dizziness or spastic bladder. Clinically, MS may occur as a relapsing-remitting or chronic. Unfortunately, each type eventually leads to the irreversible progression of the CNS and progression of neurological symptoms. Read full text »
Videos
Pictures
Documents









